Maynard Um
-
-
-
-
-
-
-
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
-
-
-
-
-
-
-
CNS Pharmaceuticals names three executives to new leadership team
-
-
-
-
-
-
-
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
-
-
-
-
-
-
-
CNS Pharmaceuticals announces 1-for-12 reverse stock split
-
-
-
-
-
-
-
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
CNS Pharmaceuticals (CNSP) Provides Update on Current Cash Position and NASDAQ Listing
-
-
-
-
-
-
-
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
-
443,991 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

